Vikshakthi Pharma Labs Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 19-12-2024
- Paid Up Capital ₹ 2.00 M
as on 19-12-2024
- Company Age 23 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.31 Cr
as on 19-12-2024
- Satisfied Charges ₹ 1.30 M
as on 19-12-2024
- Revenue 0.65%
(FY 2022)
- Profit -23.79%
(FY 2022)
- Ebitda 10.55%
(FY 2022)
- Net Worth 19.55%
(FY 2022)
- Total Assets -2.99%
(FY 2022)
About Vikshakthi Pharma Labs
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹3.31 Cr. The company has closed loans amounting to ₹1.30 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Srivatsava and Sharada Kutnikar serve as directors at the Company.
- CIN/LLPIN
U29297KA2001PTC028864
- Company No.
028864
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Apr 2001
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- LocationMysore., Karnataka
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vikshakthi Pharma Labs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Srivatsava  | Director | 04-Apr-2001 | Current |
| Sharada Kutnikar | Director | 04-Apr-2001 | Current |
Financial Performance of Vikshakthi Pharma Labs.
Vikshakthi Pharma Labs Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 0.65% increase. The company also saw a substantial fall in profitability, with a 23.79% decrease in profit. The company's net worth Soared by an impressive increase of 19.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vikshakthi Pharma Labs?
In 2019, Vikshakthi Pharma Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tech Vibrant Innovative Solutions Private LimitedActive 15 years 2 monthsRajesh Srivatsava is a mutual person
Itchamps Software Private LimitedActive 19 years 10 monthsRajesh Srivatsava and Sharada Kutnikar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 21 Jun 2023 | ₹3.31 Cr | Open |
State Babk Of India Creation Date: 22 Jun 2001 | ₹1.30 M | Satisfied |
How Many Employees Work at Vikshakthi Pharma Labs?
Unlock and access historical data on people associated with Vikshakthi Pharma Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vikshakthi Pharma Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vikshakthi Pharma Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
